Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medipal Holdings's share price for the quarter that ended in Dec. 2023 was 円2285.5. Medipal Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 210 Mil. Therefore, Medipal Holdings's market cap for the quarter that ended in Dec. 2023 was 円479,994 Mil.
Medipal Holdings's quarterly market cap
increased
from Jun. 2023 (円501,372 Mil) to Sep. 2023 (円535,059 Mil) but then
declined
from Sep. 2023 (円535,059 Mil) to Dec. 2023 (円479,994 Mil).
Medipal Holdings's annual market cap
declined
from Mar. 2021 (円445,961 Mil) to Mar. 2022 (円423,073 Mil) and
declined
from Mar. 2022 (円423,073 Mil) to Mar. 2023 (円378,771 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medipal Holdings's Enterprise Value for Today is 円323,187 Mil.
Medipal Holdings Market Cap Historical Data
The historical data trend for Medipal Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medipal Holdings's Market Cap
For the Medical Distribution subindustry, Medipal Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings's Market Cap Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's Market Cap falls into.
Medipal Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Medipal Holdings's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings (TSE:7459) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Medipal Holdings Market Cap Related Terms
Thank you for viewing the detailed overview of Medipal Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:7459 has been successfully added to your 